| Date Filed | Type | Description |
| 08/03/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/31/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/25/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 07/25/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 07/25/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 07/25/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/25/2023 |
8-K
| Quarterly results |
| 06/08/2023 |
424B4
| Form 424B4 - Prospectus [Rule 424(b)(4)]: |
| 06/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/08/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/31/2023 |
SD
| Form SD - Specialized disclosure report: |
| 05/25/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/24/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/10/2023 |
SC 13G
| Capital Research Global Investors reports a 10.5% stake in GE HealthCare Technologies Inc. |
| 05/09/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 05/09/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 04/25/2023 |
S-4
| Form S-4 - Registration of securities, business combinations: |
| 04/25/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 04/25/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/25/2023 |
8-K
| Quarterly results |
| 04/05/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/05/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 04/05/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/05/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/24/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/24/2023 |
8-K
| Other Events Interactive Data |
| 02/10/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/03/2023 |
8-K
| Quarterly results |
| 01/30/2023 |
8-K
| Quarterly results |
| 01/10/2023 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits ... |
| 01/04/2023 |
8-K
| Director compensation was amended/approved|
Docs:
|
"Separation and Distribution Agreement, by and between General Electric Company and GE HealthCare Technologies Inc. (f/k/a/ GE Healthcare Holding LLC), as amended.†",
"Transition Services Agreement, by and between General Electric Company and GE HealthCare Technologies Inc. (f/k/a GE Healthcare Holding LLC).†",
"Tax Matters Agreement, by and between General Electric Company and GE HealthCare Technologies Inc. (f/k/a GE Healthcare Holding LLC).†",
"Employee Matters Agreement, by and between General Electric Company and GE HealthCare Technologies Inc. (f/k/a GE Healthcare Holding LLC)",
"The cover page from this Current Report on Form 8-K, formatted in Inline XBRL",
"Real Estate Matters Agreement, by and between General Electric Company and GE HealthCare Technologies Inc. (f/k/a GE Healthcare Holding LLC)",
"Stockholder and Registration Rights Agreement, by and between General Electric Company and GE HealthCare Technologies Inc. (f/k/a GE Healthcare Holding LLC).†",
"GE HealthCare Completes Spin-Off and Begins Trading on Nasdaq" |
|
| 12/29/2022 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 12/29/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 12/29/2022 |
8-K
| Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea... |
|